Research Articles

View some of the latest research and breakthroughs articles for corneal dystrophy.

DMEK, DSO, and Gold Standards

Skip Atkins, Mentor, Fuchs Friends

In the title of her article1 published in the journal Cornea in 2022, Dr. Kathryn Colby poses an important question regarding the contemporary and emerging treatment of Fuchs Endothelial Corneal Dystrophy (FECD): “Descemet Stripping ...

The Future for the Care of Fuchs’ Dystrophy

Mark Gorovoy MD

Fuchs’ dystrophy is the most common diagnosis resulting in endothelial keratoplasty (EK), either DSAEK or DMEK, with the latter being an exact diseased tissue replacement These 2 procedures have been transformative, but progress ...

TTHX-1114: Engineered Endothelial Cell Growth Factor

William B. Trattler, MD

TTHX-1114: Engineered Growth Factor Has Potential to Treat Corneal Endothelial DeficienciesThe current standard of care for Fuchs and corneal endothelial dystrophies focuses on increasing the number and function of corneal ...

Covid-19 and Corneal Transplant Recipients

Christopher Sales, MD, MPH

Here’s the take-home message: The average corneal transplant recipient is not at increased risk for contracting COVID-19 because of their corneal transplants’ steroid eye drops. Let me walk you through why. There are 3 issues to ...

An Introduction to Fuchs’ Dystrophy for Patients

Christopher Sales, MD, MPH

Preface:I wrote the original draft of this to help my patients with Fuchs’ Endothelial Dystrophy better understand their disease and their therapeutic options. In 2018, one of my patients asked whether I’d be willing to publish it ...

High-Order Aberrations and Corneal Dystrophies

Sanjay V. Patel, MD FRCOphth

You might have heard the terms “aberrations” or “high-order aberrations”, but what are they, and do you need to worry about them? Simply put, “aberrations” are the different types of refractive error that an individual might have. ...

Dry Eye

Yuri McKee, MD

What we typically call “Dry Eyes” is really more accurately described as “Dysfunctional Tear Film”. People with this condition may have no symptoms at all or may experience a variety of conditions which may give us irritated, dry ...

My sincere condolences to Bob’s family and friends. May God bless and comfort you all in this difficult time.
Bob’s legacy in his work with the Corneal Dystrophy Foundation and Fuchs Friends was life-changing for so many over the years, including me. Bob was an invaluable source of information about Fuchs, was very candid and honest, and valued sharing important information to help Fuchs patients above considerations that could have impeded that goal. For example, a single comment Bob made in one of his posts on Fuchs Friends changed my life for the better.
There was an ongoing discussion about various top-tier cornea specialists with pros and cons being discussed. Dr. Gorovoy’s name came up, and Bob posted that if he lived near the east coast he would be Dr. Gorovoy’s patient. Understanding that Bob was perhaps the most knowledgeable and informed Fuchs patient in the world influenced me to eventually have my DSOs done by Dr. Gorovoy. They were a success and my vision is now excellent. Thanks to Bob for helping me regain my vision. Bob’s legacy will live on in the lives of the many Fuchs patients such as I whose Fuchs was successfully treated and whose lives were made better through Bob’s accomplishments.

Spanish Fort, Alabama

Skip to content